» Articles » PMID: 27989544

Use of Dual Energy X-ray Absorptiometry in Pediatric Patients

Overview
Journal Bone
Date 2016 Dec 20
PMID 27989544
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Dual Energy X-ray Absorptiometry (DXA) is a vital tool for assessing bone health in patients at risk for fragility fractures. In pediatric patients, this technology is used in conjunction with clinical fracture history to diagnosis osteoporosis and monitor treatment response. Childhood and adolescence is characterized by linear growth and bone mass accrual; thus there are important differences in the interpretation of bone measurements obtained by DXA in these young patients. This review aims to explore the current indications for DXA use and interpretation of DXA in the pediatric age group using currently available reference databases. Limitations of DXA in pediatric patients, specifically in children with short stature, will be explored. We will review several pathophysiologic mechanisms that may lead to low bone density in children, discussing representative diseases and the recommendations for monitoring bone health with DXA in these conditions. Finally, we will highlight new methods by which DXA imaging can gather additional information on bone health in children and may improve our ability to predict fractures and osteoporosis.

Citing Articles

Nutritional management and autism spectrum disorder: A systematic review.

Al-Beltagi M World J Clin Pediatr. 2024; 13(4):99649.

PMID: 39654662 PMC: 11572612. DOI: 10.5409/wjcp.v13.i4.99649.


Reference-Class Problems Are Real: Health-Adjusted Reference Classes and Low Bone Mineral Density.

Binney N J Med Philos. 2024; 49(2):128-146.

PMID: 38418083 PMC: 10938540. DOI: 10.1093/jmp/jhae005.


Reference ranges for body composition indices by dual energy X-ray absorptiometry from the Bone Mineral Density in Childhood Study Cohort.

Zemel B, Shepherd J, Grant S, Lappe J, Oberfield S, Mitchell J Am J Clin Nutr. 2023; 118(4):792-803.

PMID: 37598746 PMC: 10579045. DOI: 10.1016/j.ajcnut.2023.08.006.


Legg-Calvé-Perthes Disease Following Nephrotic Syndrome With Long-Term Steroid Use in a Three-Year-Old Boy: A Case Report.

Ueshima M, Shimasaki A, Yasu T Cureus. 2023; 15(5):e38808.

PMID: 37303366 PMC: 10250837. DOI: 10.7759/cureus.38808.


Bone health in childhood and adolescence: an overview on dual-energy X-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries.

Madhuchani D, Seneviratne S, Ward L Front Endocrinol (Lausanne). 2023; 14:1082413.

PMID: 37139332 PMC: 10150014. DOI: 10.3389/fendo.2023.1082413.


References
1.
Bianchi M, Leonard M, Bechtold S, Hogler W, Mughal M, Schonau E . Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014; 17(2):281-94. DOI: 10.1016/j.jocd.2014.01.005. View

2.
Margulies L, Horlick M, Thornton J, Wang J, Ioannidou E, Heymsfield S . Reproducibility of pediatric whole body bone and body composition measures by dual-energy X-ray absorptiometry using the GE Lunar Prodigy. J Clin Densitom. 2005; 8(3):298-304. DOI: 10.1385/jcd:8:3:298. View

3.
Dickerman J . The late effects of childhood cancer therapy. Pediatrics. 2007; 119(3):554-68. DOI: 10.1542/peds.2006-2826. View

4.
Bachrach L, Sills I . Clinical report—bone densitometry in children and adolescents. Pediatrics. 2010; 127(1):189-94. DOI: 10.1542/peds.2010-2961. View

5.
Faulkner R, Bailey D, Drinkwater D, McKay H, Arnold C, Wilkinson A . Bone densitometry in Canadian children 8-17 years of Age. Calcif Tissue Int. 1996; 59(5):344-51. DOI: 10.1007/s002239900138. View